10 Prostate Cancer Clinical Trials in San Diego, CA (2026)

Q: How do I join a clinical trial in San Diego?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Diego research site will contact you.

Recruiting Prostate Cancer Studies in San Diego

NCT03151629Recruiting

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000 men with advanced cance...

San Diego, CA5,000 participantsProstate Cancer Clinical Trials Consortium

View Study Details

NCT06952803Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

The purpose of the study is to demonstrate superiority of Saruparib (AZD5305) relative to placebo added to a standard radiation therapy (RT) + androgen deprivation therapy (ADT) regimen by assessment ...

San Diego, CAPHASE3700 participantsAstraZeneca

View Study Details

NCT06579417Recruiting

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

This is a multicenter, multinational trial to evaluate advanced MRI techniques for improved detection of clinically significant prostate cancer (csPCa). The study will enroll 500 participants at 5 cli...

San Diego, CA500 participantsUniversity of California, San Diego

View Study Details

NCT06632977Recruiting

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

This phase II trial evaluates whether genetic testing in prostate cancer is helpful in deciding which study treatment patients are assigned. Patient cancer tissue samples are obtained from a previous ...

San Diego, CAPHASE2474 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT06134232Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

A multicenter, open-label, prospective study to investigate immune boost response changes in patients with metastatic castrate-resistant prostate cancer (mCRPC)....

San Diego, CAPHASE2400 participantsDendreon

View Study Details

NCT07005154Recruiting

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to treat prostate cancer. It works by reducing the amount of the main male sex hormone, testosterone in the body. Androgen rece...

San Diego, CAPHASE2218 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT04363164Recruiting

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

Asymptomatic men without pain due to prostate cancer progressing with metastatic CRPC after treatment with combination or sequential ADT + Abi will be treated on a randomized, open label study to dete...

San Diego, CAPHASE2150 participantsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

View Study Details

NCT06879041Recruiting

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

The main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275....

San Diego, CAPHASE1136 participantsAstraZeneca

View Study Details

NCT06549465Recruiting

Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)

This is a three-part study evaluating the safety and efficacy of a PSMA-directed radioantibody (rosopatamab tetraxetan, conjugated to either In-111 or Ac-225). Part 1 will consist of one administratio...

San Diego, CAPHASE293 participantsConvergent Therapeutics

View Study Details

NCT07111507Recruiting

A Study of Tarlatamab for People With Prostate Cancer

The researchers are doing this study to find out whether tarlatamab is an effective treatment for Delta-like Protein 3 (DLL3)-positive prostate cancer that has spread to other parts of your body (meta...

San Diego, CAPHASE232 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Prostate Cancer Clinical Trials in San Diego

Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.

There are currently 10 prostate cancer clinical trials recruiting participants in San Diego, CA. These studies are seeking a combined 7,703 participants. Research is being sponsored by Prostate Cancer Clinical Trials Consortium, AstraZeneca, University of California, San Diego and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Prostate Cancer Clinical Trials in San Diego — FAQ

Are there prostate cancer clinical trials in San Diego?

Yes, there are 10 prostate cancer clinical trials currently recruiting in San Diego, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Diego?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Diego research site will contact you about next steps.

Are clinical trials in San Diego free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Diego studies also compensate for your time and travel.

What prostate cancer treatments are being tested?

The 10 active trials in San Diego are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.

Data updated September 1, 2026 from ClinicalTrials.gov